Respiratory gating systems are non-invasive guidance systems used for targeting tumors in internal organs such as the lungs, abdomen, and breast with a radiation beam. Tumors in internal organs tend to displace every time a patient breathes, thus making the administration of radiation therapy a challenge. Respiratory gating systems assist in monitoring the movement of target locations corresponding to the patient’s breathing cycle. These solutions record the wave pattern of the respiratory cycle and determine precise tumor movement corresponding to the wave pattern. In advanced treatment techniques such as intensity-modulated radiation therapy (IMRT) or image-guided radiation therapy (IGRT), respiratory gating systems are widely relied on by clinicians to monitor and compensate for tumor movement, thereby delivering higher radiation doses.
Many people believe that combining respiratory gating systems with advanced adaptive radiotherapy and gated treatment delivery should be the first form of adaptive radiotherapy. Respiratory gating systems also hold significant potential in radiation therapy in cases where tumor shape change is a big issue. One major challenge to the growth of this market is that performing respiratory gating on LINAC systems is time-consuming and not covered by incremental reimbursement. As against respiratory gating, adaptive radiotherapy is performed in real-time, thereby removing the need to follow the gating process. The margins of error in respiratory gating are also higher than in adaptive radiotherapy (3 to 5 mm), which means a larger amount of healthy tissue is affected by treatment. Significant growth in the incidence and prevalence of lung and breast cancer is the prime factor driving the demand for respiratory gate systems. Lung cancer, being the most common form of cancer prevalent worldwide, has the highest influx of radiotherapy. The incorporation of advanced technologies such as 4D visualization has further increased the precision of gate systems and therefore augmented market opportunities.
The global respiratory gating systems market is segmented on the following basis:
Products
Respiratory Gating Systems
Accessories
Usage Areas
Hospitals
Ambulatory Surgical Centers
Geography
North America
US
Canada
Europe
UK
Germany
Rest of Europe
Asia Pacific
Japan
China
Rest of APAC
Latin America
Brazil
Mexico
The Middle East and Africa
GCC
Rest of the Middle East and Africa
Key players identified for the respiratory gating systems market include but are not limited to:
Siemens Healthcare, BrainLAB, Inc., Varian Medical Systems, Anzai Medical Co. Ltd., Raditec Medical AG, Philips Healthcare, Standard Imaging Inc., General Electric Company, and others
This report offers the following:
Analysis of products, usage areas, and regions that would provide a clear understanding of the ongoing and future trends in the global respiratory gating systems market
assessment of regional market trends and scrutiny of potential customer bases
Analysis of the intensity of the challenge posed by adaptive radiotherapy
Analysis of market dynamics, such as drivers, restraints, and opportunities prevalent in the market
Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
Company profiles highlighting key information about the imperative players operating in the global respiratory gating systems market,
Frequently Asked Questions:
The market for Respiratory Gating Systems is expected to reach US$ XX Mn in 2026.
The Respiratory Gating Systems market is expected to see significant CAGR growth over the coming years,at XX%.
